Registry Personnel

James Geller, MD

James I. Geller, MD, completed undergraduate training at Dartmouth College, medical training at the Sackler School of Medicine, residency training in pediatrics at New York Medical College and pediatric hematology / oncology training at St. Jude Children's Research Hospital. His current appointment is with Cincinnati Children's Hospital Medical Center within the University of Cincinnati in the capacity of Professor of Pediatrics.

Dr. Geller is the Medical Director of the Renal and Liver Tumor Programs and Co-Director of the Retinoblastoma Program at CCHMC. His primary academic interest is the development of novel therapy options for infants, children, adolescents and young adults with solid tumors. At the institutional level, this is achieved through direct patient care and by leading our teams in clinical and research efforts in his specialty areas at Cincinnati Children’s Hospital Medical Center. At the national level, Dr. Geller is a member of the Children’s Oncology Group (COG) Renal Tumor (RTC), Liver Tumor and Central Nervous System Committees; serving as Chair for the RTC as well as Chair of the High Risk Renal Tumors Protocols including AREN1721 (study of TFE RCC), as well as oncology lead for COG studies AREN1921 (anaplastic Wilms tumor, relapsed favorable histology Wilms tumor) and the Pediatric Hepatic International Liver Tumor Trial (PHITT); AHEP1531.